Home
/ Plexium
/ Competitors

Plexium Competitors and Similar CompaniesClear all

Plexium's competitors and similar companies include PLx Pharma, UCB, Mankind Pharma and Genentech.

	Plexium Plexium is a technology drug development company.	PLx Pharma PLx Pharma is a specialty pharmaceutical company focused on its clinically-validated PLxGuard drug delivery platform.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 2017	Founding Date 2002	Founding Date 1928	Founding Date 1995	Founding Date 1976
Type	Type Private	Type Public	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations San Diego, US HQ	Locations Sparta, US HQ Houston, US Woodmere, US	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations New Delhi, IN HQ	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 6221% decrease	Employees 16100% increase	Employees 9,052	Employees 16,2532% increase	Employees 18,077
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.5 m	Valuation ($) 34.3 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $8.2m (FY, 2021)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $4.8m (FY, 2021)	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $3.4m (FY, 2021)	Gross profit €7.2b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($46.1m) (FY, 2021)	Net income €1.6b (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round $ 35m (over 5 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 215m (about 11 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 63m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 239m	Total funding raised N/A